{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:40Z","timestamp":1786985440701,"version":"build-2736575974"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014320","name":"Soft Bones","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011781","name":"Shriners Hospitals for Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.bone.2020.115300","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T12:18:09Z","timestamp":1582719489000},"page":"115300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia"],"prefix":"10.1016","volume":"134","author":[{"given":"Michael P.","family":"Whyte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Wenkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Mumm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa J.","family":"Berndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3497-3057","authenticated-orcid":false,"given":"Rajiv","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2020.115300_bb0005","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/archpedi.1948.02030020840003","article-title":"Hypophosphatasia: a new developmental anomaly","volume":"75","author":"Rathbun","year":"1948","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.bone.2020.115300_bb0010","series-title":"Genetics of Bone Biology and Skeletal Disease","first-page":"481","article-title":"Hypophosphatasia and how alkaline phosphatase promotes mineralization","author":"Whyte","year":"2018"},{"key":"10.1016\/j.bone.2020.115300_bb0015","series-title":"Principles of Bone Biology","first-page":"1525","article-title":"Hypophosphatasia: nature's window on alkaline phosphatase function in humans","author":"Whyte","year":"2020"},{"key":"10.1016\/j.bone.2020.115300_bb0020","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1359\/jbmr.2001.16.9.1724","article-title":"Hypophosphatasia: molecular diagnosis of Rathbun's original case","volume":"16","author":"Mumm","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115300_bb0025","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","article-title":"Alkaline phosphatase and hypophosphatasia","volume":"98","author":"Millan","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2020.115300_bb0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","article-title":"Hypophosphatasia: aetiology, nosology, pathogenesis, diagnosis and treatment","volume":"12","author":"Whyte","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bone.2020.115300_bb0035","first-page":"340","article-title":"Hypophosphatemia: the common denominator of all rickets","volume":"27","author":"Tiosano","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2020.115300_bb0040","article-title":"Hyperphosphatemia due to enhanced renal reclamation of phosphate in hypophosphatasia (abstract)","volume":"2","author":"Whyte","year":"1987","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115300_bb0045","article-title":"Hyperphosphatemia due to enhanced renal reclamation of phosphate in hypophosphatasia (abstract)","volume":"32A","author":"Rettinger","year":"1987","journal-title":"Clin. Res."},{"key":"10.1016\/j.bone.2020.115300_bb0050","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/jbmr.5650111010","article-title":"Creatine kinase brain isoenzyme (BB-CK) presence in serum distinguishes osteopetroses among the sclerosing bone disorders","volume":"11","author":"Whyte","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115300_bb0055","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/jbmr.130","article-title":"Elevated serum lactate dehydrogenase isoenzymes and aspartate transaminase distinguish Albers-Sch\u0151nberg disease (chloride channel 7 deficiency osteopetrosis) among the sclerosing bone disorders","volume":"25","author":"Whyte","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115300_bb0060","series-title":"Henry's Clinical Diagnosis and Management by Laboratory Methods","first-page":"195","year":"2011"},{"key":"10.1016\/j.bone.2020.115300_bb0065","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.bone.2008.02.014","article-title":"Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement","volume":"42","author":"Endo","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115300_bb0070","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI18563","article-title":"Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent","volume":"112","author":"Berndt","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2020.115300_bb0075","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00424-007-0231-5","article-title":"Biological activity of FGF-23 fragments","volume":"454","author":"Berndt","year":"2007","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bone.2020.115300_bb0080","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1021\/ac60119a033","article-title":"Microdetermination of phosphorus","volume":"28","author":"Chen","year":"1956","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bone.2020.115300_bb0085","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/BF01473295","article-title":"Eine einfache colorimetrische Methode zur Inulin-Bestimmung f\u00fcr Nieren-clearance-untersuchungen bei StoffwechselGesunden und Diabetikern","volume":"33","author":"F\u00fchr","year":"1955","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.bone.2020.115300_bb0090","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","article-title":"Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients","volume":"75","author":"Whyte","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115300_bb0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbmr.2307","article-title":"PHEX 3\u2032-UTR mutation c.*231A>G near the polyadenylation signal is a relatively common, mild, American mutation that masquerades as sporadic or X-linked recessive hypophosphatemic rickets","volume":"30","author":"Mumm","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115300_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.3955","article-title":"X-linked hypophosphatemia: uniquely mild disease associated with PHEX 3\u2032-UTR c.*231A>G mutation (a retrospective, case-control study)","author":"Smith","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115300_bb0105","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab in children with X-linked hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2020.115300_bb0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S2213-8587(18)30338-3","article-title":"Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphatemia: a multicenter, open-label, phase 2 trial","volume":"7","author":"Whyte","year":"2019","journal-title":"Lancet Diabetes & Endocrinology"},{"key":"10.1016\/j.bone.2020.115300_bb0115","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bone.2018.01.022","article-title":"Hypophosphatasia: biochemical hallmarks validate the expanded pediatric clinical nosology","volume":"110","author":"Whyte","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115300_bb0120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0031-3955(05)70485-5","article-title":"New perspectives on the biology and treatment of X-linked hypophosphatemic rickets","volume":"44","author":"Carpenter","year":"1997","journal-title":"Pediatr. Clin. N. Am."},{"key":"10.1016\/j.bone.2020.115300_bb0125","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00005792-197909000-00001","article-title":"Adult hypophosphatasia: clinical, laboratory and genetic investigation of a large kindred with review of the literature","volume":"58","author":"Whyte","year":"1979","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bone.2020.115300_bb0130","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1001\/archinte.1981.00340130158037","article-title":"Fifty-year follow up of hypophosphatasia","volume":"141","author":"Weinstein","year":"1981","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bone.2020.115300_bb0135","series-title":"Bone and Mineral Research","first-page":"175","article-title":"Alkaline phosphatase: physiologic role explored in hypophosphatasia","author":"Whyte","year":"1989"},{"key":"10.1016\/j.bone.2020.115300_bb0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ajmg.1320360105","article-title":"Infantile hypophosphatasia: autosomal recessive transmission to two related sibships","volume":"36","author":"Moore","year":"1990","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bone.2020.115300_bb0145","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1359\/jbmr.2003.18.4.624","article-title":"Marrow cell transplantation for infantile hypophosphatasia","volume":"18","author":"Whyte","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115300_bb0150","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0002-9343(82)90474-0","article-title":"Adult hypophosphatasia with chondrocalcinosis and arthropathy: variable penetrance of hypophosphatasemia in a large Oklahoma kindred","volume":"72","author":"Whyte","year":"1982","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bone.2020.115300_bb0155","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/0002-9343(57)90124-9","article-title":"Hypophosphatasia","volume":"22","author":"Fraser","year":"1957","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bone.2020.115300_bb0160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bone.2016.08.019","article-title":"Hypophosphatasia: natural history study of 101 affected children investigated at one research center","volume":"93","author":"Whyte","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115300_bb0165","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jpeds.2019.01.049","article-title":"Natural history of perinatal and infantile hypophosphatasia: a retrospective study","volume":"209","author":"Whyte","year":"2019","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bone.2020.115300_bb0170","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3476(84)80079-7","article-title":"Enzyme replacement therapy for infantile hypophosphatasia attempted by intravenous infusions of alkaline phosphatase-rich Paget plasma: results in three additional patients","volume":"105","author":"Whyte","year":"1984","journal-title":"J Pediatrics"},{"key":"10.1016\/j.bone.2020.115300_bb0175","first-page":"398b","article-title":"Marked radiographic improvement in infantile hypophosphatasia with T\u2013depleted bone marrow transplantation from a related haploidentical donor","volume":"90","author":"Martin","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bone.2020.115300_bb0180","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1210\/jc.2006-1902","article-title":"Adult hypophosphatasia treated with teriparatide","volume":"92","author":"Whyte","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2020.115300_bb0185","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1106173","article-title":"Enzyme replacement therapy in life-threatening hypophosphatasia","volume":"366","author":"Whyte","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2020.115300_bb0190","doi-asserted-by":"crossref","first-page":"e85971; 1","DOI":"10.1172\/jci.insight.85971","article-title":"Asfotase alfa therapy for children with hypophosphatasia","volume":"1","author":"Whyte","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.bone.2020.115300_bb0195","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/jbmr.5650070602","article-title":"X linked hypophosphatemic rickets: a study (with literature review) of growth response to calcitriol and phosphate therapy","volume":"7","author":"Petersen","year":"1992","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115300_bb0200","series-title":"Metabolic Basis of Inherited Disease","first-page":"1497","article-title":"Hypophosphatasia","author":"Rasmussen","year":"1983"},{"key":"10.1016\/j.bone.2020.115300_bb0205","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1172\/JCI106589","article-title":"Inorganic pyrophosphate in plasma in normal persons and in patients with hypophosphatasia, osteogenesis imperfecta, and other disorders of bone","volume":"50","author":"Russell","year":"1971","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2020.115300_bb0210","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1172\/JCI112031","article-title":"Markedly increased circulating pyridoxa1\u20135\u2032\u2013phosphate levels in hypophosphatasia: alkaline phosphatase acts in vitamin B6 metabolism","volume":"76","author":"Whyte","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2020.115300_bb0215","first-page":"1","article-title":"Phosphorylethanolamine and hypophosphatasia","volume":"15","author":"Rasmussen","year":"1968","journal-title":"Dan. Med. Bull."},{"key":"10.1016\/j.bone.2020.115300_bb0220","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/S0140-6736(64)92014-8","article-title":"Urinary pyrophosphate and urolithiasis","volume":"2","author":"Russell","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2020.115300_bb0225","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(65)91422-4","article-title":"Excretion of inorganic pyrophosphate in hypophosphatasia","author":"Russell","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2020.115300_bb0230","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0140-6736(64)91267-X","article-title":"Effect of orthophosphate on urinary pyrophosphate excretion and the prevention of urolithiasis","volume":"1","author":"Fleisch","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2020.115300_bb0235","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jid.2015.10.065","article-title":"Research progress in pseudoxanthoma elasticum and related ectopic mineralization disorders","volume":"136","author":"Li","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.bone.2020.115300_bb0240","series-title":"Online Mendelian Inheritance in Man, OMIM\u00ae","year":"2019"},{"key":"10.1016\/j.bone.2020.115300_bb0245","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2010.01.006","article-title":"Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets","volume":"86","author":"Lorenz-Depiereux","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bone.2020.115300_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.3938","article-title":"Clinical and biochemical phenotypes in a family with ENPP1 mutations","author":"Kotwal","year":"2020","journal-title":"J Bone Miner Res (in press)"},{"issue":"2","key":"10.1016\/j.bone.2020.115300_bb0255","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jaad.2010.05.023","article-title":"A randomized controlled trial of oral phosphate binders in the treatment of pseudoxanthoma elasticum","volume":"65","author":"Yoo","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bone.2020.115300_bb0260","first-page":"398","article-title":"Magnesium carbonate-containing phosphate binder prevents connective tissue mineralization in Abcc6\u2212\/\u2212 mice\u2014potential for treatment of pseudoxanthoma elasticum","volume":"2","author":"Li","year":"2009","journal-title":"CTS"},{"key":"10.1016\/j.bone.2020.115300_bb0265","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00003086-197505000-00038","article-title":"Pyrophosphate and diphosphonates in skeletal metabolism","volume":"108","author":"Russell","year":"1975","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.bone.2020.115300_bb0270","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jbmr.1752","article-title":"Severe skeletal toxicity from protracted etidronate therapy for generalized arterial calcification of infancy","volume":"28","author":"Otero","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115300_bb0275","series-title":"Phosphate Metabolism Kidney and Bone","first-page":"329","article-title":"Effects of a diphosphonate (disodium ethane-1-hydroxy-1,1-diphosphonate: EDHP) on phosphate transport in man","author":"Walton","year":"1976"},{"key":"10.1016\/j.bone.2020.115300_bb0280","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/CIRCGENETICS.108.797704","article-title":"Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy","volume":"1","author":"Rutsch","year":"2008","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.bone.2020.115300_bb0285","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jacc.2017.12.062","article-title":"Etidronate for prevention of ectopic mineralization in patients with pseudoxanthoma elasticum","volume":"71","author":"Kranenburg","year":"2018","journal-title":"J Am College Cardiology"},{"key":"10.1016\/j.bone.2020.115300_bb0290","series-title":"Alkaline Phosphatase","author":"McComb","year":"1979"},{"key":"10.1016\/j.bone.2020.115300_bb0295","first-page":"650","article-title":"Hypophosphatasia: a developmental anomaly of alkaline phosphatase","volume":"10","author":"Gorodischer","year":"1976","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bone.2020.115300_bb0300","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1042\/bst0030927","article-title":"Hypophosphatasia: enzyme studies in cultured cells and tissues","volume":"3","author":"Brydon","year":"1975","journal-title":"Biochem. Soc.Trans."},{"key":"10.1016\/j.bone.2020.115300_bb0305","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1139\/y81-049","article-title":"Renal transport of phosphate: role of alkaline phosphatase","volume":"59","author":"Petit-Clerc","year":"1981","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.bone.2020.115300_bb0310","first-page":"F235","article-title":"Absence of significant secretory flux of phosphate in the proximal convoluted tubule","volume":"232","author":"Greger","year":"1977","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bone.2020.115300_bb0315","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00584431","article-title":"On the correlation between alkaline phosphatase and phosphate transport in rat renal brush border membrane vesicles","volume":"384","author":"Storelli","year":"1980","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bone.2020.115300_bb0320","first-page":"856A","article-title":"Alkaline phosphatase-deficient hypophosphatasia fibroblasts: normal accumulation of inorganic phosphate in culture (abstract)","volume":"31","author":"Whyte","year":"1983","journal-title":"Clin. Res."},{"key":"10.1016\/j.bone.2020.115300_bb0325","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1016\/S0021-9258(20)81948-6","article-title":"Selective removal of alkaline phosphatase from renal brush-border membrane and sodium-dependent brush-border membrane transport","volume":"258","author":"Yusufi","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115300_bb0330","first-page":"397","article-title":"Studies on rabbit kidney brush border membranes: relationship between phosphate transport, alkaline phosphatase and NAD","volume":"13","author":"Yusufi","year":"1987","journal-title":"Miner. Electrolyte Metab."},{"key":"10.1016\/j.bone.2020.115300_bb0335","series-title":"Osteoporosis","first-page":"373","article-title":"Phosphatonins","author":"Tebben","year":"2013"},{"key":"10.1016\/j.bone.2020.115300_bb0340","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bone.2003.10.005","article-title":"MEPE has the properties of an osteoblastic phosphatonin and minhibin","volume":"34","author":"Rowe","year":"2004","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2020.115300_bb0345","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5414\/CN108596","article-title":"Tumor induced osteomalacia: associated with elevated circulating levels of fibroblast growth factor-7 in addition to fibroblast growth factor-23","volume":"85","author":"Bansal","year":"2016","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.bone.2020.115300_bb0350","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1210\/jc.2004-0357","article-title":"Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors","volume":"90","author":"Carpenter","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2020.115300_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00774-011-0340-2","article-title":"The expanding family of hypophosphatemic syndromes","volume":"30","author":"Carpenter","year":"2012","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2020.115300_bb0360","series-title":"Genetics of Bone Biology and Skeletal Disease","first-page":"759","article-title":"Heritable renal phosphate wasting disorders","author":"Drezner","year":"2018"},{"key":"10.1016\/j.bone.2020.115300_bb0365","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/jcp.24312","article-title":"An integrated understanding of the physiological response to elevated extracellular phosphate","volume":"228","author":"Camalier","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bone.2020.115300_bb0370","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2213-8587(18)30307-3","article-title":"Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial","volume":"7","author":"Whyte","year":"2019","journal-title":"Lancet Diabetes & Endocrinology"},{"key":"10.1016\/j.bone.2020.115300_bb0375","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bone.2018.12.011","article-title":"Five-year efficacy and safety of asfotase alfa for adults and adolescents with hypophosphatasia","volume":"121","author":"Kishnani","year":"2019","journal-title":"Bone"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220300806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220300806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:48:06Z","timestamp":1757612886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220300806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":75,"alternative-id":["S8756328220300806"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115300","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115300","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115300"}}